Phase IA Clinical Trial Evaluating the Tolerability, Pharmacokinetics, and Analgesic Efficacy of an Intrathecally Administered Neurotensin A Analogue in Central Neuropathic Pain Following Spinal Cord Injury.

Sang, Christine N

Phase IA Clinical Trial Evaluating the Tolerability, Pharmacokinetics, and Analgesic Efficacy of an Intrathecally Administered Neurotensin A Analogue in Central Neuropathic Pain Following Spinal Cord Injury. [electronic resource] - Clinical pharmacology in drug development Jul 2016 - 250-8 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article

2160-7648

10.1002/cpdd.253 doi


Analgesics--administration & dosage
Dose-Response Relationship, Drug
Glycoproteins--administration & dosage
Humans
Injections, Spinal
Maximum Tolerated Dose
Models, Biological
Neuralgia--drug therapy
Neuropeptides--administration & dosage
Neurotensin--analogs & derivatives
Spinal Cord Injuries--drug therapy
Treatment Outcome